BioCentury
ARTICLE | Company News

Caliper, NovaScreen Biosciences Corp. deal

October 10, 2005 7:00 AM UTC

CALP completed its previously announced acquisition of NovaScreen for $22 million, including $17.6 million in stock and $4.4 million in cash (see BioCentury, Sept.12). ...